← Browse by Condition
Medical Condition
cholangiocarcinoma
Total Trials
10
Recruiting Now
10
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for cholangiocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cholangiocarcinoma Clinical Trials
How many clinical trials are currently recruiting for cholangiocarcinoma?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for cholangiocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cholangiocarcinoma?
cholangiocarcinoma research spans Phase 1 (2 trials), Phase 2 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cholangiocarcinoma clinical trial?
Eligibility criteria for cholangiocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 4
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07714538
Recruiting
Enrollment
1,000 pts
Location
United Kingdom
Sponsor
Imperial College London
NCT06638931 Phase 2
Recruiting
Enrollment
28 pts
Location
Brazil
Sponsor
Instituto do Cancer do Estado ...
NCT06718257
Recruiting
Enrollment
300 pts
Location
China
Sponsor
Second Affiliated Hospital, Zh...
NCT07641036 Phase 1, Phase 2
Recruiting
Enrollment
30 pts
Location
China
Sponsor
Beijing Biotech
NCT04037007
Recruiting
Enrollment
320 pts
Location
Mexico
Sponsor
Coordinación de Investigación ...
NCT07025174 Phase 2
Recruiting
Enrollment
60 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT05286814 Phase 2
Recruiting
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04340986
Recruiting
Enrollment
1,250 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06840886 Phase 1
Recruiting
Enrollment
272 pts
Location
United States
Sponsor
Pheast Therapeutics
NCT07359586
Recruiting
Enrollment
1,200 pts
Location
China
Sponsor
Zhejiang University
Related Conditions
adrenal gland neoplasms (2) biliary tract cancer (2) oesophageal squamous cell carcinoma (1) oesophageal adenocarcinoma (1) gastric adenocarcinoma (1) pancreatic ductal adenocarcinoma pdac (1) hepatocellular carcinoma hcc (1) colorectal adenocarcinoma (1) urachal cancer (1) parathyroid carcinoma (1) fibrolamellar carcinoma (1) angiosarcoma (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology